Prostate Cancer - Results from #24920

Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis - Abstract September 4, 2012

Intermittent LHRH therapy in the management of castrate-resistant prostate cancer (CRPCa): Results of a multi-institutional randomized prospective clinical trial - Abstract September 4, 2012

Is PCA3 score useful in preoperative staging of a single microfocus of prostate cancer diagnosed at saturation biopsy? - Abstract September 4, 2012

Long-term disease stabilization in a patient with castration-resistant metastatic prostate cancer by the addition of lenalidomide to low-dose dexamethasone and celecoxib - Abstract September 4, 2012

Associations of lifestyle factors and anthropometric measures with repeat PSA levels during active surveillance/monitoring - Abstract September 3, 2012

Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer - Abstract September 3, 2012

Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? - Findings from a prospective national study - Abstract September 3, 2012

First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients - Abstract September 3, 2012

Evaluation of the deformation and corresponding dosimetric implications in prostate cancer treatment - Abstract September 3, 2012

On the beam direction search space in computerized non-coplanar beam angle optimization for IMRT-prostate SBRT - Abstract September 3, 2012

Green and black tea intake in relation to prostate cancer risk among Singapore Chinese - Abstract September 3, 2012

Sipuleucel-T immune parameters correlate with survival: An analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer - Abstract September 3, 2012

Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: A prospective study - Abstract September 3, 2012

Anatomically versus biologically unifocal prostate cancer: A pathological evaluation in the context of focal therapy - Abstract September 1, 2012

Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: A new era of hormonal therapies is born - Abstract September 1, 2012

Inflammation and prostate carcinogenesis - Abstract September 1, 2012

The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer - Abstract September 1, 2012

Impact of pre-implant lower urinary tract symptoms on postoperative urinary morbidity after permanent prostate brachytherapy - Abstract September 1, 2012

FDA approves Xtandi (enzalutamide) September 1, 2012

Long term results of a prospective dose escalation phase-II trial: Interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer - Abstract August 31, 2012

Page 1247 of 1437